Publication date: Oct 09, 2024
Metabolism and bioenergetics in the central nervous system play important roles in the pathophysiology of Parkinson’s disease (PD). Here, we employed a multimodal imaging approach to assess oxygenation changes in the spinal cord of the transgenic M83 murine model of PD overexpressing the mutated A53T alpha-synuclein form in comparison with non-transgenic littermates. In vivo spiral volumetric optoacoustic tomography (SVOT) was performed to assess oxygen saturation (sO) in the spinal cords of M83 mice and non-transgenic littermates. Ex vivo high-field T1-weighted (T1w) magnetic resonance imaging (MRI) at 9. 4T was used to assess volumetric alterations in the spinal cord. 3D SVOT analysis and deep learning-based automatic segmentation of T1w MRI data for the mouse spinal cord were developed for quantification. Immunostaining for phosphorylated alpha-synuclein (pS129 α-syn), as well as vascular organization (CD31 and GLUT1), was performed after MRI scan. In vivo SVOT imaging revealed a lower sO in the spinal cord of M83 mice compared to non-transgenic littermates at sub-100 μm spatial resolution. Ex vivo MRI-assisted by in-house developed deep learning-based automatic segmentation (validated by manual analysis) revealed no volumetric atrophy in the spinal cord of M83 mice compared to non-transgenic littermates at 50 μm spatial resolution. The vascular network was not impaired in the spinal cord of M83 mice in the presence of pS129 α-syn accumulation. We developed tools for deep-learning-based analysis for the segmentation of mouse spinal cord structural MRI data, and volumetric analysis of sO data. We demonstrated non-invasive high-resolution imaging of reduced sO in the absence of volumetric structural changes in the spinal cord of PD M83 mouse model.
Open Access PDF
Concepts | Keywords |
---|---|
50m | Alpha-synuclein |
Bioenergetics | Deep learning |
Littermates | Magnetic resonance imaging |
Mri | Optoacoustic imaging |
Overexpressing | Oxygen saturation |
Parkinson’s disease | |
Spinal cord |
Semantics
Type | Source | Name |
---|---|---|
drug | DRUGBANK | Oxygen |
disease | MESH | Parkinson’s disease |
pathway | REACTOME | Metabolism |
disease | MESH | atrophy |
drug | DRUGBANK | Ciclosporin |
drug | DRUGBANK | Phosphate ion |
disease | MESH | resting tremor |
disease | MESH | hypoxia |
disease | MESH | stroke |
disease | MESH | hypertension |
disease | MESH | coronary heart disease |
drug | DRUGBANK | Trestolone |
disease | MESH | ischemic stroke |